These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 10383009

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beta 2-microglobulin amyloidosis in a patient treated exclusively by continuous ambulatory peritoneal dialysis.
    Jadoul M, Noel H, van Ypersele de Strihou C.
    Am J Kidney Dis; 1990 Jan; 15(1):86-8. PubMed ID: 2403753
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis.
    Jimenez RE, Price DA, Pinkus GS, Owen WF, Lazarus JM, Kay J, Turner JR.
    Am J Surg Pathol; 1998 Jun; 22(6):729-35. PubMed ID: 9630180
    [Abstract] [Full Text] [Related]

  • 9. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
    Dervisoglu E, Anik Y, Erdogan S, Akansel G, Yilmaz A.
    Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum amyloid P component: a predictor of clinical beta 2-microglobulin amyloidosis.
    Spiegel DM, Sprague SM.
    Am J Kidney Dis; 1992 May; 19(5):427-32. PubMed ID: 1585929
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
    Brancaccio D, Gallieni M, Niwa T, Braidotti P, Coggi G.
    J Nephrol; 2000 May; 13(2):129-36. PubMed ID: 10858976
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dialysis-related amyloidosis: late finding or hidden epidemic?
    Dember LM, Jaber BL.
    Semin Dial; 2006 May; 19(2):105-9. PubMed ID: 16551286
    [Abstract] [Full Text] [Related]

  • 18. Beta2-microglobulin and renal bone disease.
    Wada T, Miyata T, Sakai H, Kurokawa K.
    Perit Dial Int; 1999 May; 19 Suppl 2():S413-6. PubMed ID: 10406556
    [Abstract] [Full Text] [Related]

  • 19. beta 2-Microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients.
    Maury CP.
    Rheumatol Int; 1990 May; 10(1):1-8. PubMed ID: 2191408
    [Abstract] [Full Text] [Related]

  • 20. Beta2-microglobulin and amyloidosis.
    Drüeke TB.
    Nephrol Dial Transplant; 2000 May; 15 Suppl 1():17-24. PubMed ID: 10737162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.